Motegi K - Search Results

1

Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.

Miyashita H, Uchida T, Mori S, Echigo S, Motegi K. Miyashita H, et al. Among authors: motegi k. Oncol Rep. 2003 Jul-Aug;10(4):1045-8. Oncol Rep. 2003. PMID: 12792768

2

Uridine phosphorylase is a potential prognostic factor in patients with oral squamous cell carcinoma.

Miyashita H, Takebayashi Y, Eliason JF, Fujimori F, Nitta Y, Sato A, Morikawa H, Ohashi A, Motegi K, Fukumoto M, Mori S, Uchida T. Miyashita H, et al. Among authors: motegi k. Cancer. 2002 Jun 1;94(11):2959-66. doi: 10.1002/cncr.10568. Cancer. 2002. PMID: 12115385 Free article.

3

Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin.

Miyashita H, Nitta Y, Mori S, Kanzaki A, Nakayama K, Terada K, Sugiyama T, Kawamura H, Sato A, Morikawa H, Motegi K, Takebayashi Y. Miyashita H, et al. Among authors: motegi k. Oral Oncol. 2003 Feb;39(2):157-62. doi: 10.1016/s1368-8375(02)00038-6. Oral Oncol. 2003. PMID: 12509969

4

Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.

Miyashita H, Mori S, Motegi K, Fukumoto M, Uchida T. Miyashita H, et al. Among authors: motegi k. Oncol Rep. 2003 Mar-Apr;10(2):455-61. Oncol Rep. 2003. PMID: 12579289

5

Quantification of uncertainties in reference and relative dose measurements, dose calculations, and patient setup in modern external beam radiotherapy.

Kinoshita N, Shimizu M, Motegi K, Tsuruta Y, Takakura T, Oguchi H, Kurokawa C. Kinoshita N, et al. Among authors: motegi k. Radiol Phys Technol. 2024 Nov 14. doi: 10.1007/s12194-024-00856-0. Online ahead of print. Radiol Phys Technol. 2024. PMID: 39541009

6

Long-Term Outcomes of Carbon Dioxide Insufflation in Thoracoscopic Esophagectomy After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.

Otsuka K, Goto S, Ariyoshi T, Yamashita T, Saito A, Kohmoto M, Kato R, Motegi K, Yajima N, Murakami M. Otsuka K, et al. Among authors: motegi k. Cureus. 2024 Jul 21;16(7):e65053. doi: 10.7759/cureus.65053. eCollection 2024 Jul. Cureus. 2024. PMID: 39171044 Free PMC article.

7

Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.

Otsuka K, Isobe J, Asai Y, Nakano T, Hattori K, Ariyoshi T, Yamashita T, Motegi K, Saito A, Kohmoto M, Hosonuma M, Kuramasu A, Baba Y, Murayama M, Narikawa Y, Toyoda H, Funayama E, Tajima K, Shida M, Hirasawa Y, Tsurui T, Ariizumi H, Ishiguro T, Suzuki R, Ohkuma R, Kubota Y, Sambe T, Tsuji M, Wada S, Kiuchi Y, Kobayashi S, Horiike A, Goto S, Murakami M, Kim YG, Tsunoda T, Yoshimura K. Otsuka K, et al. Among authors: motegi k. Cancer Immunol Immunother. 2024 Jan 27;73(2):23. doi: 10.1007/s00262-023-03608-y. Cancer Immunol Immunother. 2024. PMID: 38280026 Free PMC article.

8

Retrograde transgastric jejunostomy for nutritional management and aspiration prevention in cases with severe malignant esophageal strictures.

Yamashita T, Otsuka K, Goto S, Ariyoshi T, Motegi K, Kohmoto M, Saito A, Sato Y, Kishimoto Y, Murakami M. Yamashita T, et al. Among authors: motegi k. DEN Open. 2023 Nov 20;4(1):e321. doi: 10.1002/deo2.321. eCollection 2024 Apr. DEN Open. 2023. PMID: 38023668 Free PMC article.

9

Impact of irregular waveforms on data-driven respiratory gated PET/CT images processed using MotionFree algorithm.

Miyaji N, Miwa K, Yamashita K, Motegi K, Wagatsuma K, Kamitaka Y, Yamao T, Ishiyama M, Terauchi T. Miyaji N, et al. Among authors: motegi k. Ann Nucl Med. 2023 Dec;37(12):665-674. doi: 10.1007/s12149-023-01870-9. Epub 2023 Oct 5. Ann Nucl Med. 2023. PMID: 37796394

10

Promotion of ABCG2 gene expression by neolignans from Piper longum L.

Nishina A, Ukiya M, Motegi K, Kiryu R, Sato D, Sada M, Hori Y, Satsu H, Uemura K, Koketsu M, Ninomiya M, Myint LMM, Kimura H. Nishina A, et al. Among authors: motegi k. Biosci Biotechnol Biochem. 2023 Nov 21;87(12):1523-1531. doi: 10.1093/bbb/zbad132. Biosci Biotechnol Biochem. 2023. PMID: 37709570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters